HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weilai Dong Selected Research

Weilai Dong Research Topics

Disease

7Neoplasms (Cancer)
01/2022 - 01/2017
2Hydrocephalus (Hydrocephaly)
12/2019 - 01/2019
2Follicular Adenocarcinoma
12/2018 - 01/2018
1Chest Pain (Chest Pains)
02/2024
1Acute Coronary Syndrome
02/2024
1Endometrial Neoplasms (Endometrial Cancer)
01/2022
1Microsatellite Instability
01/2022
1Congenital Heart Defects (Congenital Heart Defect)
01/2022
1Coronary Disease (Coronary Heart Disease)
01/2022
1Turcot syndrome
01/2022
1Trigeminal Neuralgia (Tic Douloureux)
10/2020
1Facial Pain (Myofacial Pain)
10/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2019
1Adenocarcinoma
11/2019
1Carcinoma (Carcinomatosis)
11/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2019
1Vein of Galen Malformations
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Anaplastic Thyroid Carcinoma
12/2018
1Carcinogenesis
01/2018
1Lung Neoplasms (Lung Cancer)
12/2017
1Type 2 Diabetes Mellitus (MODY)
01/2017

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2019
2Immune Checkpoint InhibitorsIBA
01/2022 - 12/2017
2DNA (Deoxyribonucleic Acid)IBA
11/2019 - 01/2019
1TroponinIBA
02/2024
1Biomarkers (Surrogate Marker)IBA
01/2022
1HDL CholesterolIBA
01/2022
1pembrolizumabIBA
01/2022
1gamma-Aminobutyric Acid (GABA)IBA
10/2020
1GemininIBA
12/2019
1neratinibIBA
11/2019
1AfatinibIBA
11/2019
1copanlisibIBA
11/2019
1Cytidine DeaminaseIBA
11/2019
1EphrinsIBA
01/2019
1ChromatinIBA
01/2019
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1RacivirIBA
01/2018
1InterferonsIBA
12/2017
1AntibodiesIBA
12/2017
1Histocompatibility Antigens Class IIBA
12/2017
1Metformin (Glucophage)FDA LinkGeneric
01/2017
1Small Interfering RNA (siRNA)IBA
01/2017

Therapy/Procedure

4Therapeutics
10/2020 - 12/2017
1Drug Therapy (Chemotherapy)
01/2019
1Thyroidectomy
12/2018